{{Rsnum
|rsid=3889728
|Gene=AGT
|Chromosome=1
|position=230713085
|Orientation=minus
|GMAF=0.3104
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=AGT
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 1.7 | 22.4 | 75.9
| HCB | 23.7 | 39.5 | 36.8
| JPT | 32.5 | 50.0 | 17.5
| YRI | 0.0 | 19.4 | 80.6
| ASW | 0.0 | 0.0 | 0.0
| CHB | 23.7 | 39.5 | 36.8
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}[[rs3889728]] is a SNP in the [[AGT]] gene that, at least when part of a haplotype, has been associated with increased risk for developing [[pre-eclampsia]], but it was not reported to have the most influence of the 3 SNPs in the haplotype. The 2.1 fold increased risk (CI: 1.4-3.4, p=0.0008) for [[pre-eclampsia]] was reported for haplotype [[rs3889728]](A)-[[rs4762]](T)-[[rs699]](C).{{PMID|14638622}}

{{PMID Auto
|PMID=24978482
|Title=Polymorphisms in genes of the renin-angiotensin-aldosterone system and renal cell cancer risk: Interplay with hypertension and intakes of sodium, potassium and fluid
}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}